Publication:
EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

dc.contributor.authorsGumus, Mahmut; Geredeli, Caglayan; Ucar, Mahmut; Kaya, Serap; Demir, Hacer; Unal, Olcun Umit; Degirmenci, Mustafa; Dogu, Gamze Gokoz; Turan, Nedim; Yildirim, Nilgun; Basal, Fatma Bugdayci; Arpaci, Erkan; Karaagac, Mustafa; Harputluoglu, Hakan; Turk, Had Mehmet; Dane, Faysal; Ozkan, Metin
dc.date.accessioned2022-03-12T16:23:44Z
dc.date.accessioned2026-01-11T19:21:19Z
dc.date.available2022-03-12T16:23:44Z
dc.date.issued2017
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15028
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/226017
dc.identifier.wosWOS:000411895707135
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume35

Files